Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

Clinical trial NCT01127750 · COMPLETED

Trial details

NCT number: NCT01127750
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2010-05-01
Primary completion: 2011-10-01
Enrollment: 2417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.